210 related articles for article (PubMed ID: 23390545)
1. Association of dyslipidemia with renal outcomes in chronic kidney disease.
Chen SC; Hung CC; Kuo MC; Lee JJ; Chiu YW; Chang JM; Hwang SJ; Chen HC
PLoS One; 2013; 8(2):e55643. PubMed ID: 23390545
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients.
Voskamp PWM; van Diepen M; Dekker FW; Hoogeveen EK
Sci Rep; 2018 Feb; 8(1):3130. PubMed ID: 29449581
[TBL] [Abstract][Full Text] [Related]
3. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.
Zuo PY; Chen XL; Liu YW; Zhang R; He XX; Liu CY
Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):582-7. PubMed ID: 25921842
[TBL] [Abstract][Full Text] [Related]
4. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5.
Chiu H; Wu PY; Huang JC; Tu HP; Lin MY; Chen SC; Chang JM
Sci Rep; 2020 Jul; 10(1):12749. PubMed ID: 32728174
[TBL] [Abstract][Full Text] [Related]
5. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lipid-related ratios for prediction of chronic kidney disease stage 3 or more in Korean adults.
Kim JY; Kang HT; Lee HR; Lee YJ; Shim JY
J Korean Med Sci; 2012 Dec; 27(12):1524-9. PubMed ID: 23255852
[TBL] [Abstract][Full Text] [Related]
7. Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.
Drosos G; Ampatzidou F; Sarafidis P; Karaiskos T; Madesis A; Boutou AK
Am J Nephrol; 2018; 48(2):108-117. PubMed ID: 30110680
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
[TBL] [Abstract][Full Text] [Related]
9. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
Rahman M; Yang W; Akkina S; Alper A; Anderson AH; Appel LJ; He J; Raj DS; Schelling J; Strauss L; Teal V; Rader DJ;
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
[TBL] [Abstract][Full Text] [Related]
10. Association between dyslipidemia and chronic kidney disease: a cross-sectional study in the middle-aged and elderly Chinese population.
Liu DW; Wan J; Liu ZS; Wang P; Cheng GY; Shi XZ
Chin Med J (Engl); 2013 Apr; 126(7):1207-12. PubMed ID: 23557545
[TBL] [Abstract][Full Text] [Related]
11. Chronic Kidney Disease and Lipid Disorders.
Zubovic SV; Kristic S; Prevljak S; Pasic IS
Med Arch; 2016 Jun; 70(3):191-2. PubMed ID: 27594744
[TBL] [Abstract][Full Text] [Related]
12. Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia.
Ohsawa M; Tamura K; Wakui H; Kanaoka T; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Toya Y; Umemura S
Lipids Health Dis; 2015 Dec; 14():161. PubMed ID: 26645467
[TBL] [Abstract][Full Text] [Related]
13. Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up.
Marks A; Fluck N; Prescott GJ; Robertson LM; Simpson WG; Smith WC; Black C
Nephrol Dial Transplant; 2014 Feb; 29(2):333-41. PubMed ID: 24081862
[TBL] [Abstract][Full Text] [Related]
14. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
Lanktree MB; Thériault S; Walsh M; Paré G
Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
[TBL] [Abstract][Full Text] [Related]
15. Increased non-HDL-C level linked with a rapid rate of renal function decline in HIV-infected patients.
Hara M; Yanagisawa N; Ohta A; Momoki K; Tsuchiya K; Nitta K; Ando M
Clin Exp Nephrol; 2017 Apr; 21(2):275-282. PubMed ID: 27194410
[TBL] [Abstract][Full Text] [Related]
16. Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD.
Saland JM; Kupferman JC; Pierce CB; Flynn JT; Mitsnefes MM; Warady BA; Furth SL
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1711-1718. PubMed ID: 31712386
[TBL] [Abstract][Full Text] [Related]
17. Association of blood lipid profile with incident chronic kidney disease: A Mendelian randomization study.
Zhang YB; Sheng LT; Wei W; Guo H; Yang H; Min X; Guo K; Yang K; Zhang X; He M; Wu T; Pan A
Atherosclerosis; 2020 May; 300():19-25. PubMed ID: 32276134
[TBL] [Abstract][Full Text] [Related]
18. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
[TBL] [Abstract][Full Text] [Related]
19. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.
Ueshima K; Kasahara M; Koya D; Babazono T; Sato T; Imamoto M; Yasuno S; Fujimoto A; Tanaka S; Kimura G; Nakao K
Clin Exp Nephrol; 2013 Apr; 17(2):211-7. PubMed ID: 22948416
[TBL] [Abstract][Full Text] [Related]
20. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
